Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 444, 824-827 (14 December 2006) | doi:10.1038/nature05409; Published online 6 December 2006
Open Innovation Challenges
- More Challenges
- Powered by:
nature jobs
Chemical Reaction Engineering & Reactor Design
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
Academic Surgical Pathologists
- Northwestern University
- Chicago, Illinois, USA
Malaria: A protective paradox
Stephen L. Hoffman1
Abstract
The infectious form of the malaria parasite has thousands of proteins, making it tough to develop a vaccine for it. Narrowing down which proteins cause protective immune responses may help resolve the problem.
A vaccine against malaria would be the ideal means of preventing the hundreds of millions of cases of the disease that occur annually across the globe1. But no malaria vaccine has yet been licensed, and there is little consensus on how to develop one.
- Stephen L. Hoffman is at Sanaria Inc., 12115 Parklawn Drive, Suite L, Rockville, Maryland 20852, USA.
Email: slhoffman@sanaria.com
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Malaria vaccines?targeting infected hepatocytesNature Medicine News and Views (01 Nov 2000)
Disarming the malaria parasiteNature Medicine News and Views (01 Sep 2008)
See all 9 matches for News And ViewsRESEARCH
Attenuated Plasmodium yoelii lacking purine nucleoside phosphorylase confer protective immunityNature Medicine Letter (01 Sep 2008)
The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoitesNature Letters to Editor (14 Dec 2006)
See all 37 matches for Research